We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Scientific Presents Latest Innovation in High Volume ESR Testing

By LabMedica International staff writers
Posted on 12 Nov 2024
Print article
Image: The miniiSED ESR compact benchtop analyzer is on display at MEDICA 2024 (Photo courtesy of ALCOR)
Image: The miniiSED ESR compact benchtop analyzer is on display at MEDICA 2024 (Photo courtesy of ALCOR)

ALCOR Scientific (Smithfield, RI, USA) is attending MEDICA 2024 in Düsseldorf, the world’s largest event for the medical sector, where the company is presenting its latest innovations in high-volume erythrocyte sedimentation rate (ESR) testing.

At this year’s MEDICA, ALCOR is presenting its new iSED PRO fully automated ESR analyzer with a bi-directional interface that is designed to streamline ESR testing for busy, high-volume reference laboratories. The iSED PRO analyzer is rack-compatible and fully automated, significantly reducing the hands-on time and turnaround time required to produce an ESR result. Results are generated in seconds using a small blood sample, allowing for multiple hematology tests to be run off the same primary tube sample. iSED PRO is designed for maximum throughput while offering the flexibility to accommodate each laboratory’s unique workflow.

Among its versatile family of ESR solutions, ALCOR is also showcasing the iSED and iSED ELITE ESR analyzers which are typically suited for medium-high volume labs. These analyzers significantly improve ESR testing efficiency by generating results in seconds with the most automated ESR testing process. These automated, compact benchtop systems enable moderately complex urgent care labs to easily generate truly STAT ESR results in seconds with a small sample volume. Also on display at the trade show is the miniiSED ESR analyzer that helps urgent care centers to bring more testing services in-house. The miniiSED ESR is a compact benchtop analyzer that can generate truly STAT ESR results in seconds from a small sample volume. This allows practices to have results available during a patient visit which can positively impact patient care as well as patient satisfaction, particularly in a rheumatology practice. Operationally, miniiSED can enhance efficiency helping reduce send-out tests and allowing for more tests to be performed with one primary tube sample (compared to other ESR methods that require larger sample volumes).

Related Links:
ALCOR Scientific

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.